Serum iron and ferritin levels in patients with colorectal cancer in relation to the size, site, and disease stage of cancer

Journal of Gastroenterology

Volumn 34, Issue 2, 1999, Pages 195-199

  Li, Feng ^a   Kishida, Teruyuki ^a   Kobayashi, Masafumi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Colorectal cancer; Serum ferritin; Serum iron

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FERRITIN; HEMOGLOBIN; IRON;

ADULT; AGED; ARTICLE; ASCENDING COLON; BLEEDING; CANCER STAGING; COLORECTAL CANCER; DESCENDING COLON; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FERRITINS; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOIMMUNOASSAY;

EID: 0032906536     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050243     Document Type: Article

References (31)

1. Niitsu Y, Kohgo Y, Yokota M, et al. Radioimmunoassay of serum ferritin in patients with malignancy. Ann NY Acad Sci 1975;259:450-2.
2. Harju E, Lindberg H. Lack of iron stores in patients with diseases of the gastrointestinal tract. Surg Gynecol Obstet 1985;161:362-6.
3. Zavagno G, Nitti D, Marchet A, et al. Significance of serum ferritin in patients with gastric and colorectal cancer. Eur J Cancer Clin Oncol 1987;23:1077-8.
4. Kishida T, Sato J, Fujimori S, et al. Clinical significance of serum iron and ferritin in patients with colorectal cancer. J Gastroenterol 1994;29:19-23.
5. Kishida T, Shinozawa I, Tanaka S, et al. Significance of serum iron and ferritin in patients with colorectal adenomas. Scand J Gastroenterol 1997;32:233-7.
6. Morson BC, Sobin LH. Histological typing of intestinal tumours: intestinal histological classification of tumours. No. 15. Geneva: World Health Organization, 1976.
7. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. Ann Intern Med 1997;126:811-22.
8. Ederer F, Church TR, Mandel JS. Fecal occult blood screening in the Minnesota study: role of chance detection of lesions. J Natl Cancer Inst 1997;89:1423-8.
9. Church TR, Ederer F, Mandel JS, et al. Fecal occult blood screening in the Minnesota study: Sensitivity of the screening test. J Natl Cancer Inst 1997;89:1440-8.
10. Griffiths EK, Schapira DV. Serum ferritin and stool occult blood and colon cancer screening. Cancer Detect Prev 1991;15: 303-5.
11. Campo E, Palacin A, Benasco C, et al. Ferritin immunohistochemical localization in normal and neoplastic colon mucosa. Int J Biol Markers 1987;2:177-83.
12. Vaughn CB, Weinstein R, Bond B, et al. Ferritin content in human cancerous and noncancerous colonic tissue. Cancer Invest 1987;5:7-10.
13. Tsujino D, Yomoda Y, Sekita N, et al. Clinical study of plasma ferritin levels in patients with cancer. Gan No Rinsho 1982;28: 1633-7.
14. Sato M, Shimizu H, Kiyasu Y, et al. Clinical significance of serum ferritin determination of cancer patients in gastroenterological surgery. Nippon Shokaki Geka Gakkai Zasshi 1982;15:1379-86.
15. Hamazoe R, Osaki Y, Maeta M, et al. Clinical significance of serum ferritin level in carcinoma of the stomach and colon. Nippon Gan Chiryo Gakkai Shi 1985;20:2222-8.
16. Niitsu Y. Serum ferritin and malignancy. Rinsho Ketsueki 1980; 21:1135-43.
17. Miyoshi H, Ohshiba S, Asada S, et al. Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests. Am J Gastroenterol 1992;87:67-73.
18. 51Cr in man. Its use in the measurement of intestinal blood loss associated with hookworm infection. J Clin Invest 1957;36:1183-92.
19. Jones NCH. Measurement of red-cell loss from gastrointestinal tract, using radioactive chromium. BMdJ 1958;1:493-6.
20. Ebaugh FG, Clemens T, Rodnan G, et al. Quantitative measurement of gastrointestinal blood loss. Am J Med 1958;25:169-81.
21. Holt PR. Measurement of gastrointestinal blood loss in subjects taking aspirin. J Lab Clin Med 1960;56:717-26.
22. 51 blood loss studies. Am J Med 1961;31:259-65.
23. Grossman MI, Matsumoto KK, Lichter RJ. Fecal blood loss produced by oral and intravenous administration of various salicylates. Gastroenterology 1961;40:383-8.
24. Leonards JR. Absence of gastrointestinal bleeding following administration of acetyl-salicylic acid. J Lab Clin Med 1969;74: 911-4.
25. John DJB ST, Mcdermott FT. Influence of achlorhydria on aspirin-induced occult gastrointestinal blood loss: Studies in Addisonian pernicious anaemia. BMJ 1970;2:450-2.
26. Loebl DH, Craig RM, Culic DD, et al. Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminofen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers. JAMA 1977;237:976-81.
27. Lee GR. Iron deficiency and iron-deficiency anemia. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, editors. Wintrobe's clinical hematology. Vol 1, 9th ed. Philadelphia: Lee and Febiger; 1993. p. 808-39.
28. Yoshida Y, Aisawa T. The early clinical symptoms of colorectal cancer. In: Nishi M, editor. Daicho Gan No Rinsho. Tokyo: Herusu; 1984. p. 158-63.
29. Songster CL, Barrows GH, Jarrett DD. Immunochemical detection of fecal occult blood. The fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer 1980;45:1099-102.
30. Hanada H, Nagao M, Hayashi C, et al. Fecal occult blood and sites of colonic cancer. An analysis of false negative findings. Gan No Rinsho 1993;39:793-6.
31. Winawer SJ, Enker WE, Lightdale CJ. Malignant tumors of the colon and rectum. In: Berk JE, editor Gastroenterology. Vol IV, 4th ed. Philadelphia: WB Saunders; 1985. p. 2531-70.